Literature DB >> 2554267

Influence of selection for egg production and Marek's disease resistance on the incidence of endogenous viral genes in White Leghorns.

U Kuhnlein1, M Sabour, J S Gavora, R W Fairfull, D E Bernon.   

Abstract

The influence of selection on the frequencies of endogenous viral (ev) genes related to the avian leukosis virus was studied in two genetically distinct sets of White Leghorn strains. Each set consisted of four strains: an unselected control strain, two strains selected for egg production traits, and a strain selected for Marek's disease (MD) resistance as well as egg production traits. Eight different ev genes were observed in Set I and seven in Set II, four being common to both sets. Selection for egg production traits resulted in significant changes of the frequency of four ev genes in both sets. In Set I, increased frequencies were observed for ev-4, ev-7, and ev-8; a decreased frequency for ev-9 was observed. The ev-9 gene expresses the viral envelope protein, whereas the others are transcriptionally silent, with the possible exception of ev-7. In Set II, increased frequencies were observed for the transcriptionally silent ev-8 and for ev-15, a gene which consists of a solitary long terminal repeat. Decreased frequencies were observed for ev-18, which codes for infectious endogenous virus, and for a second ev gene of unknown phenotype. In the resistance-selected strains the frequencies of the ev genes were intermediate between those of the control strains and the strains selected for egg production traits with the exception of ev-6, which expresses the viral envelope protein, and ev-3, which expresses internal viral proteins as well as the envelope protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554267     DOI: 10.3382/ps.0681161

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  8 in total

1.  Activation of lnc-ALVE1-AS1 inhibited ALV-J replication through triggering the TLR3 pathway in chicken macrophage like cell line.

Authors:  Huan Luo; Xuming Hu; Huixian Wu; Gul Zaib; Wenxian Chai; Hengmi Cui
Journal:  Vet Res Commun       Date:  2022-06-17       Impact factor: 2.459

2.  Different endogenous viral loci in Cornish and White Plymouth rock chickens.

Authors:  H J Aarts; M C van der Hulst-van Arkel; F R Leenstra
Journal:  Theor Appl Genet       Date:  1992-11       Impact factor: 5.699

3.  Characterization of Copy Number Variation's Potential Role in Marek's Disease.

Authors:  Lingyang Xu; Yanghua He; Yi Ding; Guirong Sun; Jose Adrian Carrillo; Yaokun Li; Mona M Ghaly; Li Ma; Huanmin Zhang; George E Liu; Jiuzhou Song
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

4.  Domestic chickens activate a piRNA defense against avian leukosis virus.

Authors:  Yu Huining Sun; Li Huitong Xie; Xiaoyu Zhuo; Qiang Chen; Dalia Ghoneim; Bin Zhang; Jarra Jagne; Chengbo Yang; Xin Zhiguo Li
Journal:  Elife       Date:  2017-04-06       Impact factor: 8.140

5.  Identification and characterisation of endogenous Avian Leukosis Virus subgroup E (ALVE) insertions in chicken whole genome sequencing data.

Authors:  Janet E Fulton; David W Burt; Andrew S Mason; Ashlee R Lund; Paul M Hocking
Journal:  Mob DNA       Date:  2020-06-30

6.  Endogenous avian leukosis virus subgroup E elements of the chicken reference genome.

Authors:  Andrew S Mason; Janet E Fulton; Jacqueline Smith
Journal:  Poult Sci       Date:  2020-04-02       Impact factor: 3.352

Review 7.  Advances on genetic and genomic studies of ALV resistance.

Authors:  Guodong Mo; Ping Wei; Bowen Hu; Qinghua Nie; Xiquan Zhang
Journal:  J Anim Sci Biotechnol       Date:  2022-10-11

8.  Proviral integrations and expression of endogenous avian leucosis virus during long term selection for high and low body weight in two chicken lines.

Authors:  Sojeong Ka; Susanne Kerje; Lina Bornold; Ulrika Liljegren; Paul B Siegel; Leif Andersson; Finn Hallböök
Journal:  Retrovirology       Date:  2009-07-15       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.